Other reports are mainly indirect and family-based studies, in which a risk of gastric cancer was analyzed on the basis of the observed and expected number or incidence of GC in BRCA1/2 mutation carriers or their relatives [8–13]. The gene discussed is BRCA1; the disease is gastric cancer.